Follow
Xiaoyan Nie
Title
Cited by
Cited by
Year
Clinical pharmacy education in China
M Ryan, H Shao, L Yang, XY Nie, SD Zhai, LW Shi, WC Lubawy
American journal of pharmaceutical education 72 (6), 2008
722008
The efficacy and safety of JAK inhibitors for alopecia areata: a systematic review and meta-analysis of prospective studies
D Yan, H Fan, M Chen, L Xia, S Wang, W Dong, Q Wang, S Niu, H Rao, ...
Frontiers in Pharmacology 13, 950450, 2022
482022
The impact of the clinical pharmacist-led interventions in China: A systematic review and Meta-Analysis
S Qin, X Zhang, Y Fu, X Nie, J Liu, L Shi, Y Cui
International journal of clinical pharmacy 42, 366-377, 2020
212020
Genetic mutations in PEAR1 associated with cardiovascular outcomes in Chinese patients with acute coronary syndrome
X Nie, J Li, S Qin, Y Fu, G Liang, L Shi, H Shao, J Liu, Y Lu
Thrombosis Research 163, 77-82, 2018
212018
CYP2C19* 2 and other allelic variants affecting platelet response to clopidogrel tested by thrombelastography in patients with acute coronary syndrome
J Liu, XY Nie, Y Zhang, Y Lu, LW Shi, WM Wang
Chinese medical journal 128 (16), 2183-2188, 2015
202015
Association between P2RY12 gene polymorphisms and adverse clinical events in coronary artery disease patients treated with clopidogrel: A systematic review and meta-analysis
J Li, Y Fu, S Qin, G Liang, J Liu, X Nie, J Chen, L Shi, H Shao, Y Lu
Gene 657, 69-80, 2018
182018
Potentially inappropriate medications among elderly patients in community healthcare institutions in Beijing, China
M Fu, H Wushouer, X Nie, L Shi, X Guan, D Ross‐Degnan
Pharmacoepidemiology and Drug Safety 29 (8), 923-930, 2020
162020
Cardiovascular adverse events in chronic myeloid leukemia patients treated with nilotinib or imatinib: a systematic review, meta-analysis and integrative bioinformatics analysis
S Li, J He, X Zhang, Y Cai, J Liu, X Nie, L Shi
Frontiers in Cardiovascular Medicine 9, 966182, 2022
132022
A randomized phase I clinical trial comparing the pharmacokinetic, safety, and immunogenicity of potential biosimilar recombinant human HER2 monoclonal antibody for injection …
J Wang, S Niu, W Dong, L Wei, L Ou, T Zhang, L Zhang, X Nie, Q Wang, ...
Expert Opinion on Investigational Drugs 29 (7), 755-762, 2020
132020
Cost–effectiveness of CYP2C19 LOF-guided antiplatelet therapy in Chinese patients with acute coronary syndrome
Y Fu, X Zhang, S Qin, X Nie, L Shi, H Shao, J Liu
Pharmacogenomics 21 (1), 33-42, 2020
132020
Haplotype of platelet receptor P2RY12 gene is associated with residual clopidogrel on-treatment platelet reactivity
X Nie, J Li, Y Zhang, Y Xu, X Yang, Y Fu, G Liang, Y Lu, J Liu, L Shi
Journal of Zhejiang University. Science. B 18 (1), 37, 2017
132017
Analysis of the status of clinical pharmacist pilot training in Chinese hospitals
NJ Bao, H Shao, XY Nie, YP Wu, Q Yan, XX Li, W Yang, N Wang, K Zheng, ...
Journal of Chinese Pharmaceutical Sciences 20 (4), 410, 2011
102011
TRIPS-plus and access to medicines in China
J Chen, X Nie, P Yao, L Shi
Journal of public health policy 34, 226-238, 2013
92013
INTERNATIONAL PHARMACY EDUCATION SUPPLEMENT
M Ryan, H Shao, L Yang, XY Nie, SD Zhai
American journal of pharmaceutical education 72 (6), 129, 2008
92008
Clinical pharmacists’ involvement in pharmacogenomics testing and related services in China
X Hu, T Jia, X Zhang, C Wu, Y Zhang, J Chen, X Guan, L Shi, CY Lu, ...
Journal of Personalized Medicine 12 (8), 1267, 2022
82022
Systematic review and meta-analysis of vortioxetine for the treatment of major depressive disorder in adults
X Zhang, Y Cai, X Hu, CY Lu, X Nie, L Shi
Frontiers in Psychiatry 13, 922648, 2022
82022
Effectiveness and safety of anti-BCMA chimeric antigen receptor T-cell treatment in relapsed/refractory multiple myeloma: A comprehensive review and meta-analysis of …
D Hu, L Chen, D Yan, W Dong, M Chen, S Niu, S Wang, J Zhang, X Nie, ...
Frontiers in Pharmacology 14, 1149138, 2023
62023
Physicians’ knowledge, attitude, and experience of pharmacogenomic testing in China
T Jia, C Wu, X Hu, S Li, X Zhang, Y Cai, J Chen, L Shi, CY Lu, X Nie
Journal of Personalized Medicine 12 (12), 2021, 2022
52022
Trends in the utilization of psychotropic medications in China from 2018 to 2021
X Zhang, X Hu, Y Zhao, CY Lu, X Nie, L Shi
Frontiers in Pharmacology 13, 967826, 2022
52022
Clinical pharmacists’ knowledge of and attitudes toward pharmacogenomic testing in China
X Nie, T Jia, X Hu, S Li, X Zhang, C Wu, Y Zhang, J Chen, L Shi, CY Lu
Journal of Personalized Medicine 12 (8), 1348, 2022
42022
The system can't perform the operation now. Try again later.
Articles 1–20